Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7401 p590
20 May 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

· Intervention recording
· Packaging
· National Health Service
· Remote supervision
· Council election
· Fitness to practise (3)
· Education


Letters to the Editor

National Health Service

Discrimination or exacting identification standards?

From Ms H. B. Hawley, MRPharmS

I would like to remind my female married colleagues that they will need to have their marriage certificate ready for inspection by primary care trusts before their new electronic prescription service smart card can be issued (even if they have never used their husband’s name socially or professionally).

My male colleagues can relax safe in the knowledge that this indignity will not be inflicted on them.

Discrimination? I think so.

Brigitte Hawley
Cranbrook, Kent

 

PHILIP BROWN, senior responsible owner, Registration Authority, Department of Health, replies:

A user of the NHS Care Records Service is able to appear in the user register in any name that he or she is entitled to use, but they have to establish this identity to a governmental standard, e-GIF (e-Government Interoperability Framework) level 3.

If a married woman uses her maiden name professionally then that is the identity she has to prove; part of the proof involves verifying “place in the community” — an address — and this is often via utility bills. If those utility bills are in the married name then a marriage certificate may be required to demonstrate that maiden name and married name are associated.

In any situation where the proofs of identity are in different names, evidence is required to connect them. The intention is to ensure that women have the necessary flexibility in registering but, quite properly, the identification standards for people about to access confidential patient data are exacting.

Send your letter to The Editor

Previous Topic (Packaging)
Next Topic (Remote supervision)

Back to Top


©The Pharmaceutical Journal